Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s): REPCF

Technology Scientific & Technical Instruments

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

Add To Watchlist

Bullboard (TSXV:RP)

View:

Post by Ingiboyon Aug 02, 2022 10:06am

Today's NR

"Independent Testing Performed by Innovacell Demonstrates the DermaPrecise™ Control Leads to Unparalleled Post-Injection Cell Survival and Viability Consistency" This is great news for ...more

136

Discussion

(0)
•••

Post by PressReleaseon Aug 02, 2022 6:00am

New Press Release - DermaPrecise(TM) Injection System Shown to Produce Consistently High Cell Count and Viability for Cell Therapy Injections

Independent Testing Performed by Innovacell Demonstrates the DermaPrecise™ Control Leads to Unparalleled Post-Injection Cell Survival and Viability ConsistencyVANCOUVER, BC / ACCESSWIRE / August 2, 2022 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"...read article.

Level Up Your Trading with BMO InvestorLine’s Enhanced Features

posted Nov 24, 2024 9:00am by Bank of Montreal

Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more

Comment by MetzGERon Jul 29, 2022 5:32am

RE:RE:RE:RE:RE:RE:RE:RE:New Press Release

I also agree we Need the CE market Approval For the Dermal injector and winning arbitration of shiseido. But Life isnt that easy I was happy that we at least saw a Little Progress and a sign of ...more

Discussion

Comment by Ingiboyon Jul 28, 2022 8:21pm

RE:RE:RE:RE:RE:RE:New Press Release

Metzger I think you might be missing something here. We all welcome the News Releases but if they don't really tell us much I think we as shareholders are entitled to comment. The first NR ...more

Discussion

Comment by Genie29jon Jul 28, 2022 7:31pm

RE:RE:RE:RE:RE:RE:New Press Release

First of all, putting pressure on them via twitter to communicate with shareholders is on them, NOT those of us tweeting. If they did their job, no negative tweets would be necessary in the first ...more

Discussion

Comment by MetzGERon Jul 28, 2022 2:59pm

RE:RE:RE:RE:RE:New Press Release

So Ingiboy and BellEnd: you say to them "don't Post any Update until commerzialization of Dermal injector or Shiseido arbitration" so 5 months silence there you have it

Discussion

Comment by MetzGERon Jul 28, 2022 11:30am

RE:RE:New Press Release

I think we don't should always nagging around here. Otherwise it would be the best option to sell your Shares If you don't believe in the success of RepliCel. For me it is positive News ...more

Discussion

Comment by MetzGERon Jul 28, 2022 10:16am

RE:New Press Release

Nobody thought that. This is Why i warned you But you put to much Hope in this forced press releases

Discussion

Post by Ingiboyon Jul 28, 2022 10:03am

New Press Release

I am not going to comment on this particular Press Release. All I am going to say here is after two press releases this week we are trading at the all time low: $.085. I think that ...more

Discussion

(0)
•••

Post by PressReleaseon Jul 28, 2022 6:00am

New Press Release - RepliCel's Manufacturing Inspected by Japan's PMDA

After over a year of pandemic-related delays, representatives of Japan's PMDA, attended at the Company's contract manufacturing facility, Innovacell, to review the manufacturing of RepliCel's NBDS cell therapy productsVANCOUVER, BC / ACCESSWIRE / July 28, 2022 / RepliCel Life Sciences Inc...read article.

(0)
•••

Post by PressReleaseon Jul 26, 2022 4:45pm

New Press Release - CORRECTION: Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing

This press release replaces the press release disseminated July 26, 2022 at 06:00 EDT. The press release contained the wrong image - one intended for a future press release. The corrected press release with the proper image is below:VANCOUVER, BC / ACCESSWIRE / July 26, 2022 / RepliCel Life...read article.

Comment by Ingiboyon Jul 26, 2022 10:38am

RE:RE:Independent Laboratory Test Results Confirm Value of DermaPr

Any update is a welcomed thing. Good to hear the device works. My disappointment is how far along this device is in it's development. Here from twitter Nov. 11th ...more

Discussion